Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity. | J Exp Clin Cancer Res | 2023 | 37308974 | PubTator, text mining | PubMed |
| E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting "E2F2/miR-16-5p/SPTLC1" schema. | Transl Oncol | 2023 | 37300925 | PubTator, text mining | PubMed |
| Generation of Red Blood Cells from Human Pluripotent Stem Cells-An Update. | Cells | 2023 | 37296674 | PubTator, text mining | PubMed |
| Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting. | Breast J | 2023 | 37293258 | PubTator, text mining | PubMed |
| Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments. | Cancer Biol Ther | 2023 | 37272701 | PubTator, text mining | PubMed |
| Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations. | J Clin Invest | 2023 | 37252797 | PubTator, text mining | PubMed |
| Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation. | iScience | 2023 | 37250320 | PubTator, text mining | PubMed |
| BAIAP2L2 is a novel prognostic biomarker related to migration and invasion of HCC and associated with cuprotosis. | Sci Rep | 2023 | 37248248 | PubTator, text mining | PubMed |
| Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis. | Int J Mol Sci | 2023 | 37240449 | PubTator, text mining | PubMed |
| Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. | Int J Mol Sci | 2023 | 37240338 | PubTator, text mining | PubMed |
| Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies. | Int J Mol Sci | 2023 | 37240229 | PubTator, text mining | PubMed |
| CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer. | Oncogenesis | 2023 | 37230983 | PubTator, text mining | PubMed |
| Integration analysis of miRNA-mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma. | Sci Rep | 2023 | 37225858 | PubTator, text mining | PubMed |
| Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth. | Nat Commun | 2023 | 37221215 | PubTator, text mining | PubMed |
| Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression. | Epigenomes | 2023 | 37218871 | PubTator, text mining | PubMed |
| Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways. | J Cancer | 2023 | 37215446 | PubTator, text mining | PubMed |
| Role of Exosomes in the Invasion and Metastasis of Ovarian Cancer and Application Potential of Clinical Diagnosis and Treatment. | J Cancer | 2023 | 37215442 | PubTator, text mining | PubMed |
| Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A. | J Cancer | 2023 | 37215441 | PubTator, text mining | PubMed |
| Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. | Cancers (Basel) | 2023 | 37190316 | PubTator, text mining | PubMed |
| MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes. | Cancers (Basel) | 2023 | 37190222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=13